AI Consensus Investment Thesis
Unilever (ULVR) Stock Forecast and AI Rating
Unilever (ULVR) has a BUY consensus AI rating, based on 14 AI advisor configurations. The published 1-year price target is 4,774 GBX (2027), and the 5-year target is 6,599 GBX (2031).
Unilever forecast targets and rating
Final recommendation
BUY
1-Year
NEUTRAL4,774 GBX
+3.3% price return+6.8% incl. net dividendsPublished net dividend yield assumption: 3.4% per year. Assumed constant and compounded over the forecast horizon.
5-Year
BUY6,599 GBX
+42.8% price return+68.8% incl. net dividendsPublished net dividend yield assumption: 3.4% per year. Assumed constant and compounded over the forecast horizon.
Latest flagship insight
Radical Portfolio Carveouts Transform Consumer Giant Into High Margin Cash Compounder
Sharp divergence defines the analytical outlook following major portfolio unbundling. While high consensus confirms widening operating margins and robust emerging market volume growth across core personal care franchises, models split sharply over whether the pending foods separation dilutes the quoted equity series or unlocks accelerated shareholder returns.
Unilever: forecast questions
What are Unilever (ULVR)'s 1-year and 5-year price targets?
The published 1-year price target is 4,774 GBX (2027), and the 5-year target is 6,599 GBX (2031).
What is the return basis?
The 1-year price return is +3.3% and the 5-year price return is +42.8%, relative to the forecast starting price on Sep 18, 2026. Dividends are excluded. These are model projections, not guaranteed future prices.
What is Unilever's return including dividends?
Unilever's modeled return including net dividends is +6.8% over 1 year and +68.8% over 5 years, from the same forecast starting price. The publication assumes 3.4000000000000004% and 3.4000000000000004% annual net dividend yield for those horizons, respectively. Dividend yield is assumed constant and compounded over each horizon; actual payments and tax treatment can differ.
How can I compare the AI opinions and audit past Unilever forecasts?
14 AI advisor configurations contribute to this publication. AI Opinions shows individual advisor forecasts and reasoning. Forecast History preserves earlier published batches; their figures describe their original publication, not today's outlook.
This is the latest published deep-analysis batch. Audit published forecasts in full transparency
Warren Buffett (Value Purist), Machiavelli (Insider), Michael Burry (Vulture), Elon Musk (Visionary), Ray Dalio (Strategist), Universal Investor (Polymath), Superintelligence (Anthropologist), Sherlock Holmes (Whistleblower), J.P. Morgan (Titan). Some archetypes run in multiple modes, resulting in 14 advisors total.
Gemini
Claude
ChatGPTUnilever Investment Thesis
Dotted terms open concise definitions. Browse technical terms
Choose your explanation
If you invested $10,000 in Unilever at the forecast anchor (2026-09-18): $16,663 in five years versus $13,892 for S&P 500 benchmark.
* Return is calculated incl. 3.4% net dividend yield for Unilever.
The economic thesis centers on the corporate unbundling of capital-intensive food and ice cream operations into a focused, asset-light personal care enterprise. Sustained volume growth across thirty Power Brands and the delivery of overhead rationalization structurally anchor near twenty percent. However, equity valuation remains highly sensitive to terminal bond yields and the corporate finance mechanics of the pending Foods separation. The strongest counterargument highlights persistent input cost inflation in surfactants and packaging resins, which risks breaking consumer volume elasticity if retail price increases cannot fully offset upstream commodity volatility.
Key insights
- Reverse Morris Trust mechanics transfer substantial equity directly to shareholders, creating an ex-distribution price adjustment on the quoted ticker that masks total returns.
- Expanding cash margins in clinical derma and premium beauty decouple earnings from mature grocery channels, reducing enterprise vulnerability to European supermarket discounters.
- Massive cash proceeds earmarked for balance-sheet and will mechanically compress equity , driving structural per-share cash-flow accretion through 2031.
The company is slimming down by separating slow-growing food lines to focus entirely on popular beauty and personal hygiene brands like Dove. By cutting corporate waste, the business earns higher profits on everyday household essentials. While higher oil and packaging costs could squeeze if shoppers resist price hikes, dependable daily demand in growing emerging markets provides steady cash flow.
Key insights
- Spinning off food divisions gives investors new shares while temporarily resetting the parent company's stock price.
- High-margin skincare and premium hygiene products protect profitability better than budget items against store-brand supermarket rivals.
- Multi-billion-pound cash proceeds will pay down debt and fund large that boost per-share value.
20-Quarter Consensus Forecast
Price targets, returns and rationale
Frozen forecast from 18 Sept 2026. Prices in GBX; price returns exclude dividends. Each quarter is compounded from the previous quarter.
Published net dividend yield assumption: 3.4% per year. Assumed constant and compounded from the forecast anchor over each quarter’s elapsed horizon.
Scroll the table horizontally to read every column.
| Quarter | Consensus target (GBX) | Quarter price return | Cumulative price return | Cumulative return incl. net dividends | Forecast rationale |
|---|---|---|---|---|---|
| Q4 2026 | 4,669.98 | +1.06% | +1.06% | +1.91% | Year-end trading confirms underlying volume resilience across Beauty and Personal Care, absorbing commodity inflation. Cautious sentiment persists amid restrictive sovereign bond yields and preliminary UK regulatory scrutiny over the Foods divestment, keeping equity gains measured. |
| Q1 2027 | 4,808.21 | +2.96% | +4.05% | +5.81% | Full-year 2026 disclosures validate operating margins near twenty percent and robust cash conversion. Active share repurchases and clarity regarding Foods transaction terms provide positive valuation support, overcoming high interest rate headwinds across European defensive equities. |
| Q2 2027 | 4,884.66 | +1.59% | +5.71% | +8.39% | Final regulatory approvals for the McCormick transaction approach as first-quarter volumes remain solid in emerging markets. However, market anticipation of transaction mechanics and arbitrage positioning around the pending equity distribution tempers quoted price momentum. |
| Q3 2027 | 4,773.78 | -2.27% | +3.31% | +6.82% | Foods separation closes via the Reverse Morris Trust, transferring majority combined entity equity directly to shareholders. This corporate unbundling triggers an ex-distribution price adjustment on the quoted series, partially cushioned by fifteen billion dollars in cash proceeds. |
| Q4 2027 | 4,901.72 | +2.68% | +6.07% | +10.60% | Initial trading as a focused personal care pure-play reveals cleaner segment economics. Substantial cash proceeds accelerate debt paydown and share cancellations under the expanded repurchase program, initiating fundamental equity recovery from the post-distribution low. |
| Q1 2028 | 5,027.20 | +2.56% | +8.79% | +14.39% | Full-year 2027 financial statements present the first standalone pure-play reporting. Diluted earnings per share stabilize as transitional costs annualize, while a progressive dividend increase reinforces institutional demand for high-quality consumer defensive cash flows. |
| Q2 2028 | 5,139.81 | +2.24% | +11.23% | +17.93% | Moderating agricultural and energy feedstock costs relieve gross margins across home care. Premium dermatological beauty launches expand distribution across North America and Asia, driving underlying sales growth and supporting solid quarterly equity appreciation. |
| Q3 2028 | 5,200.98 | +1.19% | +12.55% | +20.33% | Emerging market subsidiaries deliver healthy volume compounding, led by Indian personal care demand. Retail price competition in European grocery channels introduces minor gross margin friction, yet programmatic share buybacks absorb secondary market selling pressure. |
| Q4 2028 | 5,340.36 | +2.68% | +15.57% | +24.60% | Accelerated share count reduction amplifies per-share owner earnings as global monetary policy begins easing. Defensive positioning ahead of year-end directs institutional capital into dependable consumer staple compounders, generating steady quarter-over-quarter price gains. |
| Q1 2029 | 5,478.68 | +2.59% | +18.56% | +28.90% | Full-year 2028 results demonstrate operating margins approaching twenty-one percent, validating overhead elimination following portfolio simplification. Pristine free cash flow generation and upgraded guidance prompt sell-side analysts to lift long-term valuation multiples. |
| Q2 2029 | 5,590.99 | +2.05% | +20.99% | +32.64% | Expansion of digital direct-to-consumer channels improves distribution efficiency and gross margins in premium personal care. Stable emerging market foreign exchange rates reduce translational drag, allowing constant-currency operational gains to flow cleanly into reported earnings. |
| Q3 2029 | 5,692.75 | +1.82% | +23.19% | +36.19% | Interim disclosures confirm double-digit expansion across clinical skincare acquisitions. Strong cash generation allows self-funded bolt-on investments without leveraging the balance sheet, maintaining positive investor sentiment and supporting steady equity compounding. |
| Q4 2029 | 5,791.23 | +1.73% | +25.32% | +39.71% | Execution of the multi-year capital return program nears completion, having retired significant equity float. Resilient holiday demand across core hygiene brands protects quarterly turnover, keeping equity valuation firmly supported despite moderate macroeconomic deceleration. |
| Q1 2030 | 5,926.75 | +2.34% | +28.26% | +44.18% | Full-year 2029 earnings beat expectations as structural productivity gains demonstrate permanence. Management outlines a refreshed multi-year capital allocation framework with enhanced dividends, triggering an institutional re-rating toward specialized personal care peer benchmarks. |
| Q2 2030 | 6,041.13 | +1.93% | +30.73% | +48.20% | Automated manufacturing nodes and AI-driven supply-chain forecasting lower unit operating costs across core product lines. Favorable volume mix in Southeast Asia compensates for sluggish Western European grocery demand, securing consistent quarterly price performance. |
| Q3 2030 | 6,139.00 | +1.62% | +32.85% | +51.86% | Steady repeat consumer purchases of daily sanitation essentials preserve volume momentum through late-cycle economic conditions. Lower debt servicing burdens and sustained share repurchases compound underlying earnings per share, driving modest equity gains. |
| Q4 2030 | 6,234.77 | +1.56% | +34.92% | +55.52% | Year-end balance sheet strength highlights conservative leverage well within investment-grade parameters. Consistent cash conversion covers committed dividend increases and routine share retirements, anchoring equity performance during broader equity market rotations. |
| Q1 2031 | 6,371.31 | +2.19% | +37.88% | +60.26% | Fiscal 2030 audited accounts confirm sustained return on invested capital above eighteen percent. The equity market permanently removes historical conglomerate discounts, pricing the company on its durable, high-margin consumer health and personal care fundamentals. |
| Q2 2031 | 6,477.71 | +1.67% | +40.18% | +64.31% | First-half trading exhibits balanced volume and price delivery across core Power Brands. Dependable operating cash flows insulate performance against localized input cost firming, maintaining stable price consolidation and attractive risk-adjusted equity yields. |
| Q3 2031 | 6,599.49 | +1.88% | +42.82% | +68.80% | The five-year transformation culminates with the enterprise firmly established as an asset-light, high-return personal care leader. Sustained per-share earnings growth and dependable cash distributions solidify terminal equity valuation at normalized historical multiples. |
Showing 2 of 20 quarters
Unilever: Risks, Valuation and Scenarios
Market consensus prices the firm as an uninspiring, low-beta constrained by mature European demographics, grocery private-label encroachment, and emerging market currency volatility. External sell-side models anchor heavily on historical low-single-digit top-line growth, treating recent revenue contractions as organic decay while heavily discounting management's ability to sustain volume-led expansion amid elevated energy prices and restrictive global monetary policy.
Paywalled preview begins: Deep Dive: detailed analysis
From this section to the end-of-preview notice below, research is provided as simplified HTML text and tables. Full access provides the complete interactive interface, charts and additional datasets.
Deep Dive
Alpha Gap & Repricing Catalysts
Where does the current market narrative diverge from our AI Opinions—and what could close the gap?
Market Narrative
What does the market currently expect? Market consensus prices the firm as an uninspiring, low-beta constrained by mature European demographics, grocery private-label encroachment, and emerging market currency volatility. External sell-side models anchor heavily on historical low-single-digit top-line growth, treating recent revenue contractions as organic decay while heavily discounting management's ability to sustain volume-led expansion amid elevated energy prices and restrictive global monetary policy.
Alpha Gap
What is the biggest difference between market expectations and our AI forecasts? The crowd underestimates value due to an acute analytical misread of corporate perimeter changes. While outside consensus interprets headline top-line contraction as fundamental weakness, forensic evidence demonstrates that unbundling ice cream and foods elevates toward twenty percent and unlocks fifteen billion dollars in separation cash. The market's blind spot overlooks volume acceleration across thirty prioritized Power Brands and superior emerging-market distribution. This disconnect creates underpricing, though ongoing regulatory review and bond-proxy duration headwinds challenge the speed of rerating.
Repricing Catalyst
What could make the market recognize and close that gap? Regulatory clearance and formal closing of the McCormick Foods combination in mid-2027 will trigger the decisive narrative shift. Receipt of fifteen billion dollars in cash alongside standalone personal-care earnings reporting will dismantle the . Demonstrating sustained volume growth above three percent while absorbing stranded overhead will force sell-side models to lift forward operating estimates, prompting institutional re-rating toward specialized beauty and personal care peers.
Sentiment and Timing
What do sentiment, volatility, and the market-recognition cycle suggest about the thesis timing?
- Greed / Fear
- Fear
- Volatility
- Low Steady
- Cycle position
- Growing Awareness
Analyses broadly agree on muted volatility and prevailing defensive skepticism, but diverge on thesis timing. While some anticipate immediate following productivity delivery, others stress that bond-proxy duration discounts and stub complexity delay valuation convergence until post-separation reporting.
Macro Regime Fit
Does the current market environment support the thesis? The macro backdrop represents a mixed setup. Restrictive central bank interest rates and elevated sovereign bond yields act as a duration headwind for defensive consumer proxies. However, non-discretionary hygiene demand and strong insulate operational cash flows, allowing robust cash generation to provide relative balance-sheet resilience during broader .
Advisor Disagreement
What do our AI Advisors disagree about most? The decisive debate centers on the corporate perimeter and valuation mechanics of the Foods separation. Forward-looking models incorporate the forty-five-billion-dollar Reverse Morris Trust combination, anticipating substantial separation cash alongside an ex-distribution price adjustment on the quoted series. In contrast, other analyses overlook the agreed transaction entirely, modeling uninterrupted on unadjusted historical perimeters. A second disagreement concerns input cost resilience: optimists expect to exceed forty-eight percent via premium brand pricing, whereas skeptics argue that price increases will break emerging market volume elasticity. Audited standalone segment reporting in 2027 will resolve this divergence.
Base-Case Forces
Near-certain positive forces
Top Drivers / Tailwinds
Near-certain forces that support the investment thesis. These forces are treated as part of the base case (more than 60% probability of occurrence). Impact columns are specific to this asset class.
Scroll to view all columns
| Driver / Tailwind | Category | Est. stock-price impact | Est. earnings impact | Why it matters |
|---|---|---|---|---|
| Power Brands portfolio premiumisation | Competitive Positioning | +18% | +16% | Concentrating capital behind thirty Power Brands representing over seventy-five percent of turnover accelerates across personal care and beauty. Superior brand equity allows selective price realization and volume share gains, expanding toward forty-seven percent. This targeted positioning protects earnings durability and commands higher through-cycle valuation multiples across retail channels. |
| Post-demerger structural margin unlocking | Operational Efficiency | +15% | +15% | Excising capital-intensive cold chains and carving out foods strips away operational bloat, allowing management to realize eight hundred million euros in overhead savings ahead of schedule. expanding toward twenty percent reflect streamlined distribution and automated manufacturing networks, permanently lowering fixed expenses and boosting enterprise cash generation through 2031. |
| Emerging market demographic volume compounding | Sector And Industry | +13% | +14% | Generating nearly sixty percent of turnover across developing economies gives the company an unmatched distribution moat in India, Southeast Asia, and Latin America. Expanding middle-class populations driving personal hygiene penetration generate durable mid-single-digit volume compounding, insulating consolidated revenue from developed-market retail fatigue and supporting sustainable long-term cash generation. |
| Disciplined compounding | Capital Allocation | +11% | +10% | Generating substantial annual allows management to execute recurring alongside dependable three-percent dividend growth. Accelerating equity retirements using cash proceeds from portfolio separations mechanically compounds per-share earnings growth. This disciplined framework provides downward price support and establishes a dependable compounding floor for patient shareholders. |
Near-certain negative forces
Top Frictions / Headwinds
Near-certain forces that could slow, cap, or damage the thesis. These forces are treated as part of the base case (more than 60% probability of occurrence). Impact columns are specific to this asset class.
Scroll to view all columns
| Friction / Headwind | Category | Est. stock-price impact | Est. earnings impact | Why it matters |
|---|---|---|---|---|
| Upstream petrochemical and | Macroeconomic And Macrofinancial | -10% | -11% | Elevated crude benchmarks and Middle Eastern shipping bottlenecks inflate procurement costs for petrochemical surfactants, plastic packaging resins, and vegetable oils. Passing these feedstock spikes to price-sensitive consumers risks volume elasticity pushback and promotional concessions, temporarily compressing across home care and nutrition before retail pricing resets fully take effect. |
| Emerging market currency depreciation drag | Macroeconomic And Macrofinancial | -8.0% | -9.0% | Generating the majority of sales in developing regions exposes reported figures to persistent foreign exchange translation drag against sterling and the euro. Elevated global interest rates and dollar strength drive recurring devaluations across peripheral currencies. While constant-currency operational growth remains sound, translational erosion diminishes reported consolidated turnover and dividend growth. |
| Private label encroachment in retail | Competitive Positioning | -7.0% | -7.0% | Persistent household budget fatigue across Europe and North America drives grocery shoppers toward discount store brands in commoditized cleaning and packaged food categories. Retailer private-label expansion constrains shelf , forcing higher promotional spending and brand advertising to defend , which caps expansion in mature Western markets. |
| Transitional stranded overhead and separation costs | Operational Efficiency | -6.0% | -7.0% | Executing major portfolio carveouts creates transitional friction, including hundreds of millions in stranded corporate overhead and multi-year restructuring expenses. Uncoupling complex IT infrastructure, shared services, and global supply agreements temporarily depresses statutory net income, creating an intermediate wedge between underlying operational progress and reported per-share statutory earnings. |
What Could Break or Accelerate the Thesis
Event Risk ScoreVery Low4/100Plausible downside scenarios
Tail Risks
Tail yet plausible downside scenarios selected for their highest potential impact.
Scroll to view all columns
| Tail scenario | Chance of Occurring | Stock Price Impact | Why plausible / what changes |
|---|---|---|---|
| Severe emerging market currency contagion | 26% | -20% | A synchronized balance-of-payments crisis and severe distress across key emerging economies could trigger acute currency devaluations by late 2027. Squeezed household purchasing power would collapse branded consumer goods volumes, while localized foreign-exchange repatriation controls would slash hard-currency remitted profits, forcing management to curtail programs and impairing equity multiples. |
| Antitrust block collapses Foods combination | 22% | -18% | Intensifying competition authority investigations in the UK and Europe could escalate into an intractable regulatory blockage by early 2027, terminating the forty-five-billion-dollar Foods combination. Unilever would lose anticipated cash windfalls, remaining burdened with legacy food overhead. This execution failure would undermine strategic credibility, paralyze , and prompt immediate valuation de-rating. |
Plausible upside scenarios
Tail Opportunities
Tail yet plausible upside scenarios selected for their highest potential impact.
Scroll to view all columns
| Tail scenario | Chance of Occurring | Stock Price Impact | Why plausible / what changes |
|---|---|---|---|
| Accelerated prestige beauty global expansion | 32% | +20% | A rapid international rollout of high-margin clinical skincare and prestige wellbeing acquisitions across untapped Asian and Middle Eastern retail channels by 2028 would ignite portfolio mix . Driven by affluent consumer demand, doubling this division's turnover would lift group past fifty percent and prompt institutional multiple re-rating toward luxury cosmetic peers. |
| Surplus cash return post separation | 30% | +16% | Monetizing retained equity stakes alongside unencumbered cash proceeds from the completed Foods separation could fund an extraordinary ten-billion-euro via special tender offer by 2029. Retiring up to eight percent of outstanding equity would dramatically accelerate diluted per-share earnings growth and trigger immediate upward multiple convergence. |
Company Financial Analysis
Unilever Earnings and Financials Analysis by AI
Financial figures available as of Sep 20, 2026. Only filings and source records available by this analysis date are included. View latest Unilever financials here.
Earnings and financials
AI Review
The headline drop in 2025 revenue to 50.5 billion euros reflects the planned separation of the ice cream business rather than falling shopper demand. Looking under the surface, core operating profit rose over five percent to 9.9 billion euros as focused management prioritized thirty high-performing brands. Recent results confirm that sales growth is being driven by healthy volume gains across personal wash and beauty rather than inflationary price hikes. While temporary separation charges and currency fluctuations weigh on reported bottom-line profits, underlying cash generation remains robust, establishing dependable recurring earnings power as corporate simplification proceeds.
Revenue, earnings, and cash flow
The table compares up to five fiscal years of revenue, net income, and free cash flow available to this analysis.
| Fiscal year | Revenue | Net income | Free cash flow |
|---|---|---|---|
| 2025 | EUR 50.5B | EUR 6B | EUR 6.4B |
| 2024 | EUR 60.8B | EUR 5.7B | EUR 7.5B |
| 2023 | EUR 59.6B | EUR 6.5B | EUR 7.7B |
| 2022 | EUR 60.1B | EUR 7.6B | EUR 5.7B |
| 2021 | EUR 52.4B | EUR 6B | EUR 6.7B |
Valuation context: historical P/E
The table compares up to five fiscal years of point-in-time valuation evidence available to this analysis.
| Fiscal year | P/E | Earnings basis | Currency basis | Ticker / reporting |
|---|---|---|---|---|
| 2025 | 12.9x | TTM | USD-normalized | GBX / EUR |
| 2024 | 11.2x | TTM | USD-normalized | GBX / EUR |
| 2023 | 16.1x | TTM | USD-normalized | GBX / -- |
| 2022 | 15.8x | Annual | USD-normalized | GBX / EUR |
| 2021 | 19.8x | Annual | USD-normalized | GBX / EUR |
P/E uses historical market capitalization and earnings known at each period. Cross-currency observations are normalized to USD using point-in-time FX rates.
Profitability and margins
AI Review
Profitability has expanded structurally as management eliminates lower-margin, seasonal businesses. Gross margin climbed to 46.9 percent in 2025, while underlying operating margin reached 20.0 percent, supported by early completion of an eight-hundred-million-euro operational productivity program. This margin expansion reflects lasting operational improvements rather than temporary pricing tricks. Concentrating sales behind thirty premium Power Brands provides strong consumer pricing power against packaging and commodity inflation. By combining cost efficiencies with a richer product mix in personal care, the business protects operating margins and ensures durable through-cycle cash generation.
The table compares up to five fiscal years of operating income and reported profitability margins.
| Fiscal year | Operating income | Operating margin | Net margin |
|---|---|---|---|
| 2025 | EUR 9.9B | 19.6% | 11.9% |
| 2024 | EUR 9.4B | 15.5% | 9.5% |
| 2023 | EUR 9.8B | 16.4% | 10.9% |
| 2022 | EUR 10.8B | 17.9% | 12.7% |
| 2021 | EUR 8.7B | 16.6% | 11.5% |
Balance sheet and leverage
AI Review
The balance sheet is structured for safety and resilience during periods of higher interest rates. Although equity shrank following the ice cream carve-out, operating profits cover interest expenses nearly ten times over, confirming that debt obligations are fully manageable. A low current ratio simply reflects standard consumer staples working capital, where customer cash is collected before suppliers are paid. Looking ahead, fifteen billion dollars in separation cash proceeds will provide substantial flexibility to extinguish debt and fund multi-billion-pound share buybacks without risking investment-grade credit ratings.
The table compares up to five fiscal years of debt, liquidity, net cash or debt, and current-ratio evidence.
| Fiscal year | Total debt | Cash + short-term investments | Net cash / (debt) | Current ratio |
|---|---|---|---|---|
| 2025 | EUR 29.6B | EUR 5.1B | EUR 25.7B net debt | 0.79x |
| 2024 | EUR 30.7B | EUR 7.6B | EUR 24.5B net debt | 0.76x |
| 2023 | EUR 28.6B | EUR 6.1B | EUR 24.4B net debt | 0.76x |
| 2022 | EUR 29.3B | EUR 5.5B | EUR 24.1B net debt | 0.75x |
| 2021 | EUR 29.7B | EUR 4.5B | EUR 26.3B net debt | 0.70x |
Net debt below zero is displayed as net cash. Current ratio is current assets divided by current liabilities.
Capex and investment intensity
AI Review
Management has deliberately lowered capital spending on physical factories, trimming capital expenditures to 2.76 percent of turnover in 2025. Exiting asset-heavy cold-chain logistics and frozen manufacturing permanently frees cash that was previously tied up in maintenance equipment. Instead of heavy industrial building, leadership is directing money into high-return areas like premium beauty formulations, factory robotics, and targeted digital advertising. This asset-light approach releases billions of euros in free cash flow, allowing the company to fund substantial dividend payouts and share buybacks while sustaining competitive brand leadership.
The table compares up to five fiscal years of capital expenditure and research-and-development investment.
| Fiscal year | Capital expenditure | R&D spend |
|---|---|---|
| 2025 | EUR 1.4B | EUR 820.9M |
| 2024 | EUR 2B | EUR 987M |
| 2023 | EUR 1.7B | EUR 949M |
| 2022 | EUR 1.6B | EUR 908M |
| 2021 | EUR 1.2B | EUR 847M |
Quarterly Forecast Scenarios
Unilever Averaged Consensus Scenarios
One row per forecast quarter. Asset scenario targets are shown in GBX; benchmark values are shown in USD.
Scroll to view all columns
| Quarter | Bear case (GBX) | Base case (GBX) | Bull case (GBX) | S&P 500 benchmark (USD) | FX (GBP/USD) |
|---|---|---|---|---|---|
| 4,482 GBX | 4,713 GBX | 4,760 GBX | $750.26 | 1.3237 | |
| 4,617 GBX | 4,858 GBX | 4,950 GBX | $736.44 | 1.3096 | |
| 4,755 GBX | 4,952 GBX | 5,099 GBX | $743.40 | 1.3087 | |
| 4,042 GBX | 4,998 GBX | 5,302 GBX | $755.15 | 1.3116 | |
| 4,204 GBX | 5,114 GBX | 5,409 GBX | $776.22 | 1.3089 | |
| 4,288 GBX | 5,254 GBX | 5,679 GBX | $787.13 | 1.3071 | |
| 4,416 GBX | 5,366 GBX | 5,849 GBX | $802.83 | 1.3128 | |
| 4,328 GBX | 5,462 GBX | 6,083 GBX | $812.05 | 1.3158 | |
| 4,588 GBX | 5,576 GBX | 6,205 GBX | $839.18 | 1.3139 | |
| 4,680 GBX | 5,728 GBX | 6,453 GBX | $850.50 | 1.3090 | |
| 4,820 GBX | 5,835 GBX | 6,647 GBX | $872.39 | 1.3128 | |
| 4,916 GBX | 5,948 GBX | 6,846 GBX | $885.51 | 1.3138 | |
| 5,015 GBX | 6,051 GBX | 6,983 GBX | $909.56 | 1.3168 | |
| 5,115 GBX | 6,204 GBX | 7,262 GBX | $916.13 | 1.3159 | |
| 5,268 GBX | 6,311 GBX | 7,480 GBX | $936.51 | 1.3216 | |
| 5,374 GBX | 6,425 GBX | 7,705 GBX | $947.34 | 1.3218 | |
| 5,428 GBX | 6,533 GBX | 7,859 GBX | $969.59 | 1.3189 | |
| 5,536 GBX | 6,684 GBX | 8,173 GBX | $979.99 | 1.3198 | |
| 5,647 GBX | 6,796 GBX | 8,418 GBX | $999.60 | 1.3236 | |
| 5,760 GBX | 6,922 GBX | 8,671 GBX | $1,012 | 1.3227 |
Showing 2 of 20 quarters
Behind the synthesis
How each opinion shapes the consensus
The reports exhibit an independently verified consensus that operating margins have inflected toward twenty percent following the completed ice cream demerger and delivery of the eight hundred million euro productivity program. A strong common pattern highlights volume-led growth across thirty core Power Brands, particularly in developing economies. However, severe analytical divergence emerges regarding portfolio perimeter changes. Several submissions fail to recognize the agreed forty-five-billion-dollar Reverse Morris Trust combination of Foods with McCormick, while others uncritically repeat distorted unadjusted trailing cash-flow metrics. The strongest credible contrarian insight demonstrates that distributing majority equity directly to shareholders creates a mechanical ex-distribution step-down on the quoted equity path rather than an uninterrupted multiple expansion. Unresolved regulatory scrutiny from the UK competition authority introduces temporary execution uncertainty. Consequently, reports incorporating primary regulatory filings and rigorous corporate finance mechanics receive dominant weights, while those relying on stale perimeters or flawed aggregates are downweighted.
Universal Investor AI
The Polymath
GPT-6 AstraThis submission provides the most rigorous, evidence-supported analysis. It verifies SEC filings, exposes accounting distortions in trailing aggregates, and correctly models the Reverse Morris Trust transaction mechanics, including the ex-distribution step-down on the quoted equity series alongside realistic five-year compounding.
Universal Investor AI
The Polymath
Opus 5This analysis demonstrates superior source independence and causal rigor, correctly evaluating both the ice cream spin-off and the McCormick Reverse Morris Trust transaction. It properly accounts for bond-proxy discount pressures, gross stranded costs, and intermediate stub volatility during portfolio unbundling.
Elon Musk AI
The Visionary
Gemini 3.8 FlashThis submission correctly captures the decisive forty-five-billion-dollar McCormick transaction and UK regulatory scrutiny. While slightly optimistic on multiple expansion and buyback velocity, its structural insight into the emerging pure-play personal care profile and cash proceeds warrants a meaningful weighting.
Superintelligence AI
The Anthropologist
Gemini 3.8 FlashThis report accurately identifies volume momentum across Power Brands and emerging market advantages, while noting the Foods demerger. However, its free cash flow yield claims rely on unadjusted aggregates, and the trajectory ignores the mechanical ex-distribution pricing step-down resulting from the Reverse Morris Trust transaction.
Sherlock Holmes AI
The Whistleblower
Gemini 3.8 FlashThis analysis offers rigorous forensic examination of post-ice cream margin accretion and capital expenditure discipline. However, it fails to incorporate the announced agreement with McCormick, omitting the substantial cash transfer, stranded corporate overhead, and equity carve-out implications for the quoted equity security.
Ray Dalio AI
The Strategist
Gemini 3.8 FlashThis perspective offers excellent macroeconomic reasoning regarding stagflation, monetary tightening, and consumer staple duration dynamics. Its primary limitation is total silence regarding the agreed Foods carve-out, preventing it from modeling the mechanical asset transfers and transitional stranded costs impacting the quoted series.
Universal Investor AI
The Polymath
Gemini 3.8 FlashThe analysis effectively captures the operational baseline after the ice cream demerger, highlighting emerging market distribution moats and productivity program delivery. However, it lacks awareness of the McCormick Foods combination, underestimating transitional friction costs and the structural reconfiguration of the quoted entity.
Universal Investor AI
The Polymath
Gemini 3.8 FlashThe analysis correctly assesses the operational turnaround from SKU rationalization and power-brand focus under the Growth Action Plan. Nonetheless, it treats the ice cream separation as an ongoing process rather than completed, and entirely omits the transformative McCormick transaction and associated corporate restructuring charges.
J.P. Morgan AI
The Titan
Gemini 3.8 FlashThis perspective provides valuable institutional clarity on first-half 2026 volume acceleration and gross margin defense. However, it completely ignores the Foods transaction, projecting an aggressive path that fails to account for the ex-distribution share price adjustment inherent in the Reverse Morris Trust structure.
Michael Burry AI
The Vulture
Gemini 3.8 FlashThe report provides diligent forensic scrutiny of working capital, debt maturity profiles, and productivity savings under leadership changes. However, it ignores the Foods carve-out entirely and unhelpfully incorporates unadjusted, currency-mismatched cash flow figures, limiting its path reliability over the five-year horizon.
Superintelligence AI
The Anthropologist
Gemini 3.8 FlashWhile soundly identifying defensive hygiene demand and core pricing elasticity, this perspective leans heavily on biological metaphors and relies on flawed unadjusted cash flow aggregates. Crucially, it completely overlooks the agreed Foods division divestment and its structural effect on the quoted share price.
Niccolo Machiavelli AI
The Insider
Gemini 3.8 FlashThis perspective correctly identifies governance pressures and administrative cost pruning under board restructuring. However, its thesis hinges primarily on monetizing the retained ice cream stake while completely missing the agreed Foods transaction, thereby mischaracterizing future portfolio composition and capital returns.
Warren Buffett AI
The Value Seeker
Gemini 3.8 FlashAlthough offering sound classical insights on brand moats and pricing power, this submission severely errs by uncritically adopting unadjusted trailing figures of fourteen billion dollars in free cash flow. Furthermore, omitting the agreed Foods divestiture renders its long-term valuation trajectory unreliable.
Warren Buffett AI
The Value Seeker
Gemini 3.8 FlashThis report accurately details productivity gains and volume stabilization in core hygiene brands. However, it duplicates flawed trailing free cash flow metrics and completely ignores the transformational Foods agreement, resulting in an unadjusted path that fails to reflect corporate perimeter shifts.
Research Provenance
References & Context
This Unilever consensus analysis combines structured market evidence with independent AI-agent forecasts. External references below are limited to sources recorded by the researcher agents for this forecast batch.
Primary analysis inputs
- iPulse AI Multi-Agent Forecasts — independent analyst personas, model outputs, and consensus synthesis.
- iPulse AI Global Events Context — macroeconomic, geopolitical, regulatory, and industry-event context.
- Structured market history — prices, distributions, volatility, identifiers, and listing metadata.
- Company earnings and financial statements — revenue, profitability, balance-sheet, cash-flow, and investment trends.
- Researcher web evidence — public sources consulted to challenge and contextualize the forecast thesis.
Independent AI Advisor panel
- AI Advisors
- 14
- AI Researchers
- 11
- AI Thinkers
- 3
Sources retained from AI Researcher searches
Asset-specific · Researcher webShowing the top 15 of 51 deduplicated sources retained for this batch.
- 01https://www.sec.gov/Archives/edgar/data/217410/000165495426001155/a6773s.htm?utm_source=openaisec.gov
- 02https://www.sec.gov/Archives/edgar/data/217410/000199937126015710/mkcv-425_072326.htm?utm_source=openaisec.gov
- 03mkc-20260228sec.gov
- 04ul-20251231sec.gov
- 05ul-20260630sec.gov
- 06ul-20260630sec.gov
- 07UNILEVER PLC - Form 425 - FY2026sec.gov
- 08UNILEVER PLC - Form 6-K - FY2026sec.gov
- 09UNILEVER PLC - Form 6-K - FY2026sec.gov
- 102026 First Half Results Desire at Scale powering strong H1 performanceunilever.com
- 11ULVR Stock Forecast - Unilever PLC - Alpha Spreadalphaspread.com
- 12Unilever PLC (ULVR) stock price prediction 2026–2030bitget.com
- 13Unilever H1 2026 slides: volume growth accelerates to 5.5% in Q2 By Investing.comca.investing.com
- 14McCormick buys Unilever's food business in deal that values it at nearly $45 billioncnbc.com
- 15Unilever plc (via Public) / Building resilience, driving growth: inside Unilever’s AI-powered supply chainebs.publicnow.com
And 36 more sources were used and retained in the batch inventory.
Context retained with this Consensus
The same public-safe market, global-event, and fundamental context supplied to the AI Advisor panel.
Global context snapshot
2025 Full-Year Global Market and World-Events Context
Download Archived SnapshotCoverage 2025-01-01 to 2025-12-31 · Knowledge cutoff 2025-12-31
This full-year context package covers the principal geopolitical, economic, monetary-policy, technology, trade, energy, and institutional developments that shaped global markets during 2025. It gives the forecasting model a chronological account of major world events together with their likely transmission into growth, inflation, interest rates, supply chains, commodities, currencies, public markets, and sector-level investment conditions.
The package also includes monthly and quarterly macroeconomic and cross-asset reference tables spanning US and international growth, central-bank policy, sovereign yields, major equity indices, foreign exchange, energy, industrial and precious metals, and digital assets. Quarterly and full-year high-impact summaries are integrated; monthly quantitative series remain working values pending final audit, and that qualification is part of the preserved context.
| Top 3 Market Shifts From File | Date | Status |
|---|---|---|
| DeepSeek shock and AI economics reset | 2025-01-27 | OPEN ENDED TREND |
| US tariff regime escalation and trade-system rupture | 2025-02-01 | ACTIVE POLICY REGIME |
| Federal Reserve easing cycle after a prolonged hold | 2025-09-17 | ACTIVE POLICY REGIME |
Representative Sources of the Context File
And more sources from the retained context package.
2026 Year-to-Date Global Market and World-Events Context Through September 20
Download Archived SnapshotCoverage 2026-01-01 to 2026-09-20 · Knowledge cutoff 2026-09-20
January 1-September 20, 2026: monetary tightening, energy security, trade restrictions, AI financing and divergent growth; five leading market themes.
Fed raised rates to 3.75%-4.00%; ECB hike is in force and BOJ increase starts September 24. Markets through September 18, bitcoin through September 19.
| Top 3 Market Shifts From File | Date | Status |
|---|---|---|
| Renewed monetary tightening amid persistent inflation | 2026-01-30 | ACTIVE POLICY REGIME |
| Iran/Hormuz conflict and wider energy-security disruption | 2026-02-28 | ONGOING |
| Tariff legal reset and strategic supply restrictions | 2026-02-20 | ACTIVE POLICY REGIME |
Representative Sources of the Context File
And more sources from the retained context package.
Fundamental context
Income statement
9 fieldsdepreciationAndAmortization · ebit · ebitda · grossProfit · +5 more fields
Balance sheet
12 fieldscash · commonStockSharesOutstanding · longTermDebt · netDebt · +8 more fields
Cash flow
5 fieldscapitalExpenditures · dividendsPaid · freeCashFlow · salePurchaseOfStock · +1 more field
annual: 2014-12-31–2025-12-31, 12 periods; quarterly: 2023-09-30–2026-06-30, 8 periods
Currencies cited: EUR, GBP, GBX, USD (quote GBX; primary reporting EUR; converted/valuation USD; normalization GBP).
End of the paywalled preview
The excerpt from Deep Dive: detailed analysis to this notice is the simplified paywalled content included on this page. A signed-in, verified account with the required subscription provides the full interactive interface and the additional research, datasets and tools listed below.
Those additional materials are not included in this preview and cannot be revealed by removing its visual restrictions.
Additional with full access
Individual AI Advisor reports
- Investment theses
- Bull and bear scenarios and alpha signals
- Drivers, headwinds, risks and opportunities
- Quarterly forecast rationale
- Advisor research references and configuration
Additional datasets and interactive tools
- Interactive forecast comparisons
- Available detailed financial statements
- Market history and corporate-action adjustments
- Eligible historical publication workspaces
Explore complete public research examples
These public assets show the complete AI Consensus research. Their findings concern those assets, not this report.